The research work reported in the current paper was aimed at disclosing the effects of ApoA1 and an ApoA1 mimetic peptide (Ac-F3,1418A-NH2) on the malignant phenotype of ovarian cancer cells, particularly focusing on cell viability, invasiveness and the potential to synergize with platinum. Here, APOA1 is linked to ovarian cancer.